U.S. markets open in 8 hours 8 minutes

Mitesco, Inc. (MITI)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0250-0.0350 (-58.33%)
At close: 02:26PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0600
BidN/A x N/A
AskN/A x N/A
Day's Range0.0250 - 0.0260
52 Week Range0.0200 - 3.9400
Avg. Volume1,135
Market Cap132,769
Beta (5Y Monthly)-0.15
PE Ratio (TTM)N/A
EPS (TTM)-5.6000
Earnings DateDec 07, 2023 - Dec 13, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for MITI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: Perrigo Company PLCPerrigo, founded in 1887, is a leading manufacturer of generic over-the-counter healthcare products and supplier of infant formulas for the store-brand market. Perrigo's private-label consumer products encompass a variety of cold/allergy, gastrointestinal, first aid, motion sickness, vitamin, smoking cessation, and other remedies. The company has a market cap of approximately $4 billion after divesting its RX pharmaceutical business in 2021. Headquartered in Dublin, Ireland, Perrigo has approximately 10,000 employees.
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more
  • GlobeNewswire

    Mitesco Appoints Mr. Allen Plunk to its Board of Directors

    MINNEAPOLIS, MN, July 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Mitesco, Inc. (OTCQB: MITI) (, the “Company” or “Mitesco”) today announced that effective today, it has appointed Mr. Allen Plunk to its Board of Directors. This follows a recent assessment of its healthcare operations and coincides with its decision to place new emphasis on building out its acquisition of healthcare technology and services entities. Ms. Shelia Schweitzer, Chairman of the Board for Mitesco,

  • GlobeNewswire

    Mitesco Inc. Appoints Sheila Schweitzer Chairman of the Board and COO

    MINNEAPOLIS, MN, June 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Mitesco, Inc. (OTCQB: MITI and today announced that effective today, it has appointed Ms. Sheila Schweitzer, a member of the Board of Directors since 2021, to the position of Chairman, replacing Mr. Tom Brodmerkel, who has completed his term as Chair. Mr. Brodmerkel will remain as CFO and Board member. Ms. Schweitzer was also appointed to the newly created position of Chief Operating Officer (COO), primaril

  • GlobeNewswire

    Mitesco Moves Emphasis to Acquisitions & Strategic Initiatives

    MINNEAPOLIS, MN, May 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Mitesco, Inc. (OTCQB: MITI and, the “Company” or “Mitesco”) today is updating its shareholders as it moves to emphasize its long-held direction to acquire healthcare related businesses, targeting predominantly technology and services. With regard to the progress of its project aimed at reshaping The Good Clinic's business operations to align with the realities of the current capital markets, it has recently d